Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.38 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.38 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2656634 | 0.85 | GCGR (0.50) | MAPTSMN1; SMN2MCL1LMNANPC1 | |
| SCHEMBL2655857 | 0.84 | GCGR (0.46) | MAPTSMN1; SMN2NPC1EPHX2 | |
| SCHEMBL2657602 | 0.81 | MAPT (0.47) | MAPTSMN1; SMN2NPC1EPHX2 | |
| SCHEMBL2656545 | 0.80 | MAPT (0.45) | MAPTSMN1; SMN2MCL1CYP1A2CYP3A4 | |
| SCHEMBL2653571 | 0.77 | ADRB2 (0.41) | MAPTSMN1; SMN2LMNAALDH1A1NPC1 | |
| SCHEMBL2655457 | 0.75 | NPC1 (0.44) | MAPTSMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL2655997 | 0.75 | GCGR (0.61) | NPC1EPHX2 | |
| SCHEMBL2655051 | 0.74 | GCGR (0.55) | — | |
| SCHEMBL8879516 | 0.72 | MAPT (0.82) | MAPTSMN1; SMN2LMNAALDH1A1NPC1 | |
| SCHEMBL23782641 | 0.72 | HPGD (0.61) | MAPTSMN1; SMN2CYP1A2CYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1951659-A2 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | Eli Lilly & Company (US) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007114855-A2 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2007-10-11 | — | — | WO | disclosed |